SOLU-CORTEF (hydrocortisone sodium succinate) by Pfizer is clinical pharmacology glucocorticoids, naturally occurring and synthetic, are adrenocortical steroids that are readily absorbed from the gastrointestinal tract. First approved in 1955.
Drug data last refreshed 3h ago · AI intelligence enriched 3d ago
SOLU-CORTEF is an intravenous/intramuscular injectable formulation of hydrocortisone sodium succinate, a rapid-acting glucocorticoid with potent anti-inflammatory and immunosuppressive properties. It is used to treat acute adrenocortical insufficiency, severe inflammatory conditions, and shock states requiring immediate high-dose corticosteroid intervention. The water-soluble sodium succinate ester enables rapid IV administration and achieves detectable therapeutic effects within one hour.
As a legacy product approaching loss of exclusivity, the brand team is likely in optimization mode with focus on cost management and hospital formulary retention rather than growth investment.
CLINICAL PHARMACOLOGY Glucocorticoids, naturally occurring and synthetic, are adrenocortical steroids that are readily absorbed from the gastrointestinal tract. Naturally occurring glucocorticoids (hydrocortisone and cortisone), which also have salt-retaining properties, are used as replacement…
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Worked on SOLU-CORTEF at Pfizer? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Upgrade to Pro to access Medicare Part D spending data and other premium pharma intelligence.
Upgrade to Pro — $25/moUpgrade to Pro to access CMS Part B ASP pricing data and other premium pharma intelligence.
Upgrade to Pro — $25/moCareers on SOLU-CORTEF focus on commercial execution, hospital relationships, and cost management in a mature, off-patent market rather than growth strategy or innovation. This role suits professionals seeking stability in an established franchise or those with hospital/IDN commercial expertise, but offers limited career expansion in product development or clinical innovation.